Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial-Reference-Cited by-同舟云学术

Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial

Published:2018-07-06 Issue:10 Volume:20 Page:2435-2441
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Reznik Yves¹²^ORCID,Habteab Aklilu³,Castaneda Javier³,Shin John⁴,Joubert Michael¹²

Affiliation:

1. Department of Endocrinology and Diabetology; Côte de Nacre Regional Hospital Center; Caen France

2. University of Caen Basse-Normandie, Medical School; Caen France

3. Medtronic Bakken Research Center; Maastricht The Netherlands

4. Medtronic Diabetes; Northridge California

Funder

Medtronic International Trading Sarl, Tolochenaz, Switzerland. The study was sponsored by Medtronic International Trading Sarl, Tolochenaz, Switzerland.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13398/fullpdf

Reference29 articles.

1. Management of hyperglycaemia in type 2 diabetes 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2015

2. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients;Riddle;Diabetes Care,2003

3. Three-year efficacy of complex insulin regimens in type 2 diabetes;Holman;N Engl J Med,2009

4. Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes;Meneghini;Diabetes Obes Metab,2013

5. The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries;Khunti;Diabetes Obes Metab,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basal Hyperglycemia Contributes More Than 50% to Time in Range in Pregnant Women With Type 1 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2024-04-30

2. Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study;Advances in Therapy;2022-04-16

3. A new approach for investigating the relative contribution of basal glucose and postprandial glucose to HbA1C;Nutrition & Diabetes;2021-06

4. Efficacy and safety of exenatide as add‐on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double‐blind trial;Diabetes, Obesity and Metabolism;2020-10-30

5. Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies;Journal of Diabetes Science and Technology;2020-06-01